Trial intelligence / Profile preview

Propan-ol-1 60% Surgical Hand Antisepsis

NCT04446923Phase 4Completed

Sponsor
Complutense University of Madrid
Start
Jun 2020
Primary completion
Jul 2020
Countries
1
01

Overview

Phase 4, randomised, open-label trial in surgical site infection (SSI) (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: Reduction of bacterial load immediately after hand scrub at 5 minutes. Started Jun 2020; status: completed.

02

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT04446923.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04446923.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call